falsefalse

Post-Conference Perspectives: MOUNTAINEER Trials in GI Malignancies - Episode 3

Biomarker Testing and Next-Generation Sequencing Inform Modern Treatment Strategies for mCRC

Dr. Bekaii-Saab shares the approach his practice takes to essential biomarker testing and next-generation sequencing in order to improve patient outcomes.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Recent Advancements and Current Areas of Focus in the Treatment of mCRC
    EP. 2: HER2 as a Potential Drug Target and its Prevalence in GI Malignancies
    Now Viewing
    EP. 3: Biomarker Testing and Next-Generation Sequencing Inform Modern Treatment Strategies for mCRC
    EP. 4: MOUNTAINEER Trial: Rationale, Results and Clinical Implications
    EP. 5: Promising Early Data from GI Malignancy Trials

    Related Content:

    Post-Conference Perspectives: MOUNTAINEER Trials in GI MalignanciesGastrointestinal CancerOncLive News Network®
    Dr Chan on Unmet Needs Addressed by the FDA Approval of Cabozantinib for pNET and epNET
    The Evolution of ctDNA Assays in CRC
    How ctDNA Is Informing Ongoing Trials in CRC
    x